PT-141 is a cutting-edge cyclic melanocortin agonist that exhibits potential in the treatment of sexual dysfunction. This novel compound functions by enhancing specific receptors within the body, resulting to improved sexual function. Research studies have suggested that PT-141 has the potential to remarkably manage a variety of sexual dysfunction